Endava Ltd. DAVA 深 滬
等待開盤 06-05 09:30:00 美东时间
2.9006
-0.069
-2.34%
華盛通- 最 高3.09
- 今 開2.98
- 成交量 32.22万股
- 最 低 2.885
- 昨 收 2.97
- 總市值 1.53亿
- 52周最高 16.0599
- 市盈率 靜 6.22
- 換手率 0.61%
- 52周最低 2.885
- 委 比 14.16%
- 總股本 5284.27万
- 歷史最高 172.41
- 量 比 0.93
- 振 幅 6.90%
- 歷史最低 2.885
- 每 手 1
- 風險率 3.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Guggenheim Downgrades Endava to Neutral
Guggenheim analyst Jonathan Lee downgrades Endava (NYSE:DAVA) from Buy to Neutral.
05-27 20:57
美股大行评级 | 英伟达绩后获11家大行集体上调目标价；劳氏、ELF、Intuit、VF等惨遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx药业"超配"评级，目标价从84美元升至96美元；Ascendiant Capital：维持Liqtech国际"买入"评级，目标价从4.3美元升至4.4美元
05-22 10:18
Needham Maintains Buy on Endava, Lowers Price Target to $5
Needham analyst Mayank Tandon maintains Endava (NYSE:DAVA) with a Buy and lowers the price target from $7 to $5.
05-22 01:08
Full Transcript: Endava Q3 2026 Earnings Call
On Thursday, Endava (NYSE:DAVA) discussed third-quarter financial results durin...
05-21 21:12
Endava shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY26 guidance below estimates. Also, the company issued Q4 guidance below estimates.
Endava shares are trading lower after the company reported worse-than-expected ...
05-21 21:06
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Gainers PicoCELA (NASDAQ:PCLA) shares rose 46.4% to $2.05 during Thursday's pr...
05-21 20:06
Endava Lowers FY2026 Adj EPS Guidance from $1.10-$1.18 to $0.61-$0.66 vs $0.79 Est; Lowers FY2026 Sales Guidance from $1.008B-$1.028B to $972.956M-$978.348M vs $996.730M Est
Endava (NYSE:DAVA) lowers FY2026 Adj EPS guidance from $1.10-$1.18 to $0.61-$0.66 vs $0.79 analyst estimate. Lowers FY2026 sales outlook from $1.008 billion-$1.028 billion to $972.956 million-$978.348 million vs $996.730
05-21 19:26
Endava Q3 Adj. EPS $0.07 Misses $0.20 Estimate, Sales $240.662M Miss $249.690M Estimate
Endava (NYSE:DAVA) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.20 by 65 percent. This is a 83.72 percent decrease over earnings of $0.43 per share from the same period
05-21 19:22
Earnings Scheduled For May 21, 2026
Companies Reporting Before The Bell • Cato (NYSE:CATO) is projected to report e...
05-21 19:11
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
